Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,419.94 -18.71 (-0.22%) Bitcoin USD
67,254.35 +1,416.89 (+2.15%) CMC Crypto 200
1,369.08 -4.76 (-0.35%)
Amicus Therapeutics, Inc. (FOLD)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 11:43AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.81B |
| Enterprise value | 3.02B |
| Trailing P/E | N/A |
| Forward P/E | 72.99 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 6.69 |
| Price/book (mrq) | 21.53 |
| Enterprise value/revenue | 7.13 |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.79 |
| 52-week change 3 | -20.17% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 14.57 |
| 52-week low 3 | 9.02 |
| 50-day moving average 3 | 10.93 |
| 200-day moving average 3 | 11.96 |
Share statistics
| Avg vol (3-month) 3 | 3.07M |
| Avg vol (10-day) 3 | 2.92M |
| Shares outstanding 5 | 296.2M |
| Implied shares outstanding 6 | 296.2M |
| Float 8 | 238.52M |
| % held by insiders 1 | 0.72% |
| % held by institutions 1 | 109.59% |
| Shares short (30 Apr 2024) 4 | 28.77M |
| Short ratio (30 Apr 2024) 4 | 10.68 |
| Short % of float (30 Apr 2024) 4 | 9.77% |
| Short % of shares outstanding (30 Apr 2024) 4 | 9.71% |
| Shares short (prior month 28 Mar 2024) 4 | 32.49M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | -34.73% |
| Operating margin (ttm) | -19.63% |
Management effectiveness
| Return on assets (ttm) | -5.08% |
| Return on equity (ttm) | -126.10% |
Income statement
| Revenue (ttm) | 423.49M |
| Revenue per share (ttm) | 1.42 |
| Quarterly revenue growth (yoy) | 28.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -49.02M |
| Net income avi to common (ttm) | -147.07M |
| Diluted EPS (ttm) | -0.49 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 239.6M |
| Total cash per share (mrq) | 0.81 |
| Total debt (mrq) | 444.49M |
| Total debt/equity (mrq) | 340.10% |
| Current ratio (mrq) | 3.04 |
| Book value per share (mrq) | 0.44 |
Cash flow statement
| Operating cash flow (ttm) | -80.72M |
| Levered free cash flow (ttm) | -37.5M |
© 2024 Yahoo. All rights reserved.